Hedgehog Pathway Inhibitors against Tumor Microenvironment
Targeting the hedgehog (HH) pathway to treat aggressive cancers of the brain, breast, pancreas, and prostate has been ongoing for decades. <i>Gli</i> gene amplifications have been long discovered within malignant glioma patients, and since then, inhibitors against HH pathway-associated m...
Guardado en:
Autores principales: | Silpa Gampala, Jer-Yen Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95a90f41897142178dd6197ea5a31afc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cullin3 (CUL3) suppresses proliferation, migration and phenotypic transformation of PDGF-BB-stimulated vascular smooth muscle cells and mitigates inflammatory response by repressing Hedgehog signaling pathway
por: Yuluan Xiang, et al.
Publicado: (2021) -
The Hippo Signaling Pathway: The Trader of Tumor Microenvironment
por: Duo Yang, et al.
Publicado: (2021) -
Effect of kaempferol on hedgehog signaling pathway in rats with ‐‐chronic atrophic gastritis – Based on network pharmacological screening and experimental verification
por: Wenling Tu, et al.
Publicado: (2022) -
Single-Cell RNA Sequencing Reveals Multiple Pathways and the Tumor Microenvironment Could Lead to Chemotherapy Resistance in Cervical Cancer
por: Meijia Gu, et al.
Publicado: (2021) -
Role and inhibition of GLI1 protein in cancer
por: Mastrangelo E, et al.
Publicado: (2018)